Explore the words cloud of the AllergyBLOCK project. It provides you a very rough idea of what is the project "AllergyBLOCK" about.
The following table provides information about the project.
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
|Coordinator Country||France [FR]|
|Total cost||185˙076 €|
|EC max contribution||185˙076 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2015-10-01 to 2017-09-30|
Take a look of project's partnership.
|1||INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE||FR (PARIS)||coordinator||161˙941.00|
|2||INSTITUT PASTEUR||FR (PARIS CEDEX 15)||participant||23˙134.00|
Food allergies are chronic diseases of increasing prevalence for which there is no approved treatment other than food allergen avoidance. Among all food allergies, peanut allergy is a particularly important public health problem since peanut allergy tends to persist throughout life and is more likely than other types of food allergies to cause severe shock (i.e., “anaphylaxis”) and death. The current paradigm states that peanut allergy is mostly triggered by IgE antibodies. Evidence derived from mouse models indicates that some IgG isotypes can also mediate allergic reactions, but the roles of human IgG in peanut allergy remain unknown.
Among the potential treatments for peanut allergy under investigation, oral immunotherapy (OIT) appears very promising since subjects completing OIT tolerate food challenges despite persistent high-titers of IgE in the blood. OIT consists of the administration of slowly increasing doses of the allergenic food and is associated with the production of large levels of IgG, but a direct link between these antibodies and the beneficial effects of OIT has not been demonstrated.
We hypothesize that peanut allergic patients produce both pro-allergic and protective IgG, and that successful OIT is associated with an increased production of protective IgG that are particularly potent at blocking the allergic reaction. We propose to test this hypothesis by developing and exploiting humanized mouse models of peanut allergy, combined with the use of clinical samples and purified IgG from peanut allergic patients completing a phase 2 OIT clinical trial. Finally, we aim at establishing the proof of concept that recombinant protective human IgG could be used to treat peanut allergy and improve the safety and efficiency of current OIT protocols.
|year||authors and title||journal||last update|
Laurent L. Reber, Riccardo Sibilano, Philipp Starkl, Axel Roers, Michele A. Grimbaldeston, Mindy Tsai, Nicolas Gaudenzio, Stephen J. Galli
Imaging protective mast cells in living mice during severe contact hypersensitivity
published pages: online journal, ISSN: 2379-3708, DOI: 10.1172/jci.insight.92900
|JCI Insight 2/9||2019-06-13|
HÃ©loÃ¯se Beutier, Caitlin M. Gillis, Bruno Iannascoli, OphÃ©lie Godon, Patrick England, Riccardo Sibilano, Laurent L. Reber, Stephen J. Galli, Mark S. Cragg, Nico Van Rooijen, David A. Mancardi, Pierre Bruhns, Friederike JÃ¶nsson
IgG subclasses determine pathways of anaphylaxis in mice
published pages: 269-280.e7, ISSN: 0091-6749, DOI: 10.1016/j.jaci.2016.03.028
|Journal of Allergy and Clinical Immunology 139/1||2019-06-13|
Laurent L. Reber, Caitlin M. Gillis, Philipp Starkl, Friederike JÃ¶nsson, Riccardo Sibilano, Thomas Marichal, Nicolas Gaudenzio, Marion BÃ©rard, Stephan Rogalla, Christopher H. Contag, Pierre Bruhns, Stephen J. Galli
Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide
published pages: 1249-1258, ISSN: 0022-1007, DOI: 10.1084/jem.20161238
|The Journal of Experimental Medicine 214/5||2019-06-13|
Laurent L. Reber, Joseph D. Hernandez, Stephen J. Galli
The pathophysiology of anaphylaxis
published pages: 335-348, ISSN: 0091-6749, DOI: 10.1016/j.jaci.2017.06.003
|Journal of Allergy and Clinical Immunology 140/2||2019-06-13|
Bianca Balbino, Riccardo Sibilano, Philipp Starkl, Thomas Marichal, Nicolas Gaudenzio, Hajime Karasuyama, Pierre Bruhns, Mindy Tsai, Laurent L. Reber, Stephen J. Galli
Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis
published pages: 584-596.e10, ISSN: 0091-6749, DOI: 10.1016/j.jaci.2016.05.047
|Journal of Allergy and Clinical Immunology 139/2||2019-06-13|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERGYBLOCK" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ALLERGYBLOCK" are provided by the European Opendata Portal: CORDIS opendata.
New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling.Read More
Cholinergic and NMDAR-dependent recruitment of Layer 1 Interneuron shapes cortical motor Processing through network States ModulationRead More
Two Are Better Than One: Bimetallic Catalysts for the Conversion of Lignin-Derived Aryl-EthersRead More